Literature DB >> 3016496

Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.

K A Neve, P B Molinoff.   

Abstract

The turnover of beta 1- and beta 2-adrenergic receptors was measured after both isoproterenol-induced down-regulation and irreversible blockade of receptors. Changes in the density of receptors were quantified using the radioligands 125I-iodopindolol and 125I-iodocyanopindolol. Treatment of intact L6 myoblasts or C6 glioma cells with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivated beta-adrenergic receptors on membranes prepared from these cells. At a concentration of 100 microM EEDQ, more than 90% of beta 1- and beta 2-adrenergic receptors were inactivated within 2 hr of treatment. Recovery of beta-adrenergic receptors on intact cells after inactivation by EEDQ required more than 24 hr and was prevented by cycloheximide, an inhibitor of protein synthesis. The kinetics of recovery of the density of receptors were analyzed in terms of a model that allows estimation of the rate constants for receptor appearance in and disappearance from the membrane, assuming that the rate of appearance of receptors is constant and the rate of disappearance of receptors is proportional to the number of receptors. Beta 2-Adrenergic receptors on L6 myoblasts were incorporated into the membrane at a rate of 28 fmol/mg of protein/hr and had a half-life of 12.6 hr. On C6 glioma cells, Beta 1- and beta 2-adrenergic receptors appeared at rates of 13.3 and 6.6 fmol/mg of protein/hr, respectively, with half-lives of 9.4 and 6.4 hr. Recovery of receptors on C6 cells after isoproterenol-induced down-regulation was inhibited by cycloheximide. The rate of recovery of beta 1- and beta 2-adrenergic receptors was reduced after treatment with isoproterenol for 8 hr when compared to recovery after treatment with EEDQ. The major effect of treatment with isoproterenol was a persistent decrease in the rate of appearance of beta 1- and beta 2-adrenergic receptors (rate of synthesis and insertion into the membrane after treatment with isoproterenol = 4.0 fmol/mg of protein/hr). Since treatment with isoproterenol did not alter the rate of cell division or total protein synthesis, the isoproterenol-induced alteration was probably a specific effect on the rate of synthesis of beta-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016496

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2.

Authors:  C Cayla; S Schaak; C Roquelaine; C Gales; F Quinchon; H Paris
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 2.  The connexin turnover, an important modulating factor of the level of cell-to-cell junctional communication: comparison with other integral membrane proteins.

Authors:  Jean-Claude Hervé; Mickaël Derangeon; Bouchaib Bahbouhi; Marc Mesnil; Denis Sarrouilhe
Journal:  J Membr Biol       Date:  2007-08-01       Impact factor: 1.843

3.  Ontogeny of renal beta adrenoceptors in the sheep.

Authors:  C C Felder; M M Piccio; A M McKelvey; K T Nakamura; J E Robillard; P A Jose
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.

Authors:  K Y Vinod; M N Subhash; B N Srinivas
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

Review 5.  Beta-adrenergic receptor-coupled adenylate cyclase. Biochemical mechanisms of regulation.

Authors:  D R Sibley; R J Lefkowitz
Journal:  Mol Neurobiol       Date:  1987 Spring-Summer       Impact factor: 5.590

6.  Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants.

Authors:  C Schmeer; F Obregón; M Urbina; L Lima
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

7.  Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors.

Authors:  George Vaniotis; Irina Glazkova; Clémence Merlen; Carter Smith; Louis R Villeneuve; David Chatenet; Michel Therien; Alain Fournier; Artavazd Tadevosyan; Phan Trieu; Stanley Nattel; Terence E Hébert; Bruce G Allen
Journal:  J Mol Cell Cardiol       Date:  2013-05-17       Impact factor: 5.000

8.  5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells.

Authors:  Robert Meller; Joseph M Babity; David G Grahame-Smith
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

9.  Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements.

Authors:  R F Thomas; B D Holt; D A Schwinn; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

10.  Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance.

Authors:  Liam T Loftus; Rosaria Gala; Tao Yang; Veronica J Jessick; Michelle D Ashley; Andrea N Ordonez; Simon J Thompson; Roger P Simon; Robert Meller
Journal:  Brain Res       Date:  2009-03-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.